Doug Rubinson

GI Medical Oncologist At Dana-Farber. Pancreatic cancer researcher, runner, cyclist, med educator. Tweets are not medical advice. Please refrain from lawsuits.

[Doug Rubinson @Labrat3]

@jflier Caveat mTor

[Doug Rubinson @Labrat3]

@MarissaLee_DO @ASCO I was crying in my living room watching the virtual stream.

[Doug Rubinson @Labrat3]

@MBTA @MBTA_CR The mTicket app is failing to register my email address to buy tickets to “Boston Stadium” for the Workd Cup. What is going on?

[Doug Rubinson @Labrat3]

@TenMyou5 @PokemonGOHubNet Where did it say guaranteed? I thought it was 1 in 20 odds. Re: ratta, about a 2% chance of not seeing one out of 2,000 caught. That's pretty lousy luck, but not outlandish.

[Doug Rubinson @Labrat3]

@TenMyou5 @PokemonGOHubNet The odds of not getting a shiny in 20 raids is 1 in 8, so not unreasonable to just be bad luck.

[Cancer Cell @Cancer_Cell]

Online Now: Hidden spark: From cold to hot in BRAF colorectal cancer https://t.co/XmOtFJuNCl

[Doug Rubinson @Labrat3]

According to Apple News’s email this morning Trump has a lot on his plate.

[Doug Rubinson @Labrat3]

@US_FDA @AACR An important topic being discussed today. It is time to standardize DPYD testing prior to first exposure to fluoropyrimidines. Each story of a DPD-related death is heartbreaking as it could have been prevented with an inexpensive test. #AACRSciencePolicy

[Doug Rubinson @Labrat3]

@decoding_engg The 52nd Mersenne prime should be announced within days pending final proof per https://t.co/79XuqgUzUd. The first new Mersenne prime in 6 years.

[Doug Rubinson @Labrat3]

Are they going to show a better replays USWNT sure looked offside to me. I’ll take the goal either way.

[Doug Rubinson @Labrat3]

https://t.co/HEnV6SGjUy

Vladimir: Well, shall we go?
Estragon: Yes, let's go.
*They do not move.
*a phone booth appears in a haze
*curtain

[Dana-Farber News @DanaFarberNews]

First effective use of immunotherapy for the most common subtype of #ColorectalCancer reported in @NatureMedicine. This early-stage research shows promise for metastatic disease. #CancerResearch #ClinicalTrial

CC: @DanaFarber @ben_schlechter

Read more: https://t.co/QhxtjSoy6L

[Dana-Farber News @DanaFarberNews]

Congratulations to Joel Katz, who was named as Senior Vice President for Education @DanaFarber:

https://t.co/FwzOc1CwZz

[brennan @BrennanCaldwell]

life is just adding more and more nyt games to your morning routine until that’s all there is

[Doug Rubinson @Labrat3]

In oncology, we spend a lot of money/effort trying to find new drugs. The best drug in GI cancers continues to be 5-Fluorouracil (5-FU) - a drug which costs <$1/dose. We could likely be using this drug far better. Here's a first step: https://t.co/nhEQCcEI94

[Doug Rubinson @Labrat3]

@adamssperling Eastern connecting to TWA

[Doug Rubinson @Labrat3]

The man behind me on my flight identified Robin Williams as his favorite current comedian, and then indicated that he was torn, as he felt Gallagher is a genius (present tense).

[Doug Rubinson @Labrat3]

In Newport VT with a few zillion umbraphiles.

[Doug Rubinson @Labrat3]

A year ago, I sent Andy Aguirre and Ryan Corcoran an email asking if there was any way I could target my patient's NRAS G12C mutated colon cancer. Sotorasib is a pan-RASG12C inhibitor capable of driving clinical response in NRASG12C cancers https://t.co/oPA6oUrLbo

[Doug Rubinson @Labrat3]

Friends with a passion for medical education - there is a really exciting opportunity at Dana Farber to transform education. DFCI is creating an Institute Level Senior VP faculty position for an MD with a track record and passion for education. https://t.co/UcK8UAmPkW